Navigation Links
Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business
Date:2/25/2008

als.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.

Cautionary Statement Regarding Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward- looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding our product performance, regulatory approval of our products, competitive offerings, our growth strategy, and our market position. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and, future business decisions made by us
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents
2. Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007
3. Boston Scientific to Participate in Merrill Lynch Conference
4. CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium
5. Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses
6. Boston Scientific Completes Sale of Auditory Business and Drug Pump Development Program
7. Boston Scientific Announces Results for Third Quarter Ended September 30, 2007
8. Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA
9. The 58th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, Nov. 2-6
10. Boston Scientific Announces European Approval of Next-Generation Implantable Defibrillator
11. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)CAMBRIDGE, Mass., Dec. 2 TechConnect World, an event bringing together the leaders in technology development and product integration in cleantech, nanotech, biotech and MEMS, announced the December 1
(Date:12/2/2009)RESTON, Va., Dec. 2 /PRNewswire-Asia-FirstCall/ -- Emerald Dairy, Inc.,("Emerald Dairy" or the "Company") (OTC Bulletin Board: EMDY), a leading,producer and distributor of infant and children,s formul
(Date:12/2/2009)SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The world is going through,extraordinary times; markets are in turmoil and uncertainty is part of many,businesses and industries. It turns out that the pharma ind
(Date:12/1/2009)Dr. Kerry Solomon announced that he has joined Carolina Eyecare Physicians and has launched his redesigned website at www.DrKerrySolomon.com , which was developed by Medical Consulting Group. Dr. So
Breaking Biology Technology:Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
...e too many worries right now. As the CEO of Craig...inates classified advertising, he leads a company ...d since the dismissal of a housing discrimination ...rganization could have one less controversy to dea...e credit for designing the company,s multi-city ar...
...has closed a public offering of three million shar...on for general corporate purposes. , ,The company ...at $3.75 per share, marketed to institutional inve...viously filed with the Securities and Exchange Co...-media product called MediaSite, will use the proc...
...ind an economic year in which some new investments... state,s tech economy positioned itself to prosper...ld be even better, but the investment climate must... cold shoulder to ideas that would hurt Wisconsin,...at,s in store for the New Year? Several themes tha...
Other Biology Technology:Craigslist exec strives to keep the Internet neutral 2Craigslist exec strives to keep the Internet neutral 3Craigslist exec strives to keep the Internet neutral 4Wisconsin's high-growth economy: '07 predictions 2Wisconsin's high-growth economy: '07 predictions 3Wisconsin's high-growth economy: '07 predictions 4
(Date:12/3/2009)Grand Rapids, Mich. (Dec. 3, 2009) Van Andel Research Institute (VARI) researchers have determined precisely how the plant hormone abscisic acid (ABA) works at the molecular level to help plants re
(Date:12/3/2009)Spanish researchers have measured CO2 levels for the past three years in the troposphere (lower atmosphere) over a sparsely inhabited rural area near Valladolid. The results, which are the first of th
(Date:12/2/2009)PHILADELPHIA Children exposed to secondhand cigarette smoke have an increased risk of developing lung cancer in adulthood, even if they never smoked. , Results of this study are published in Cance
Breaking Biology News(10 mins):VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3CO2 levels rising in troposphere over rural areas 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Similarities of pumping blood and oil examined 10922 1Similarities of pumping blood and oil examined 10922 2Similarities of pumping blood and oil examined 10922 3Reportlinker Adds The Future of Senior Nutrition 3A Key Ingredients Strategic Issues and Targeted Opportunities for Older Consumers 62263 1Reportlinker Adds The Future of Senior Nutrition 3A Key Ingredients Strategic Issues and Targeted Opportunities for Older Consumers 62263 2Reportlinker Adds The Future of Senior Nutrition 3A Key Ingredients Strategic Issues and Targeted Opportunities for Older Consumers 62263 3Reportlinker Adds The Future of Senior Nutrition 3A Key Ingredients Strategic Issues and Targeted Opportunities for Older Consumers 62263 4Reportlinker Adds The Future of Senior Nutrition 3A Key Ingredients Strategic Issues and Targeted Opportunities for Older Consumers 62263 5Reportlinker Adds The Future of Senior Nutrition 3A Key Ingredients Strategic Issues and Targeted Opportunities for Older Consumers 62263 6Reportlinker Adds The Future of Senior Nutrition 3A Key Ingredients Strategic Issues and Targeted Opportunities for Older Consumers 62263 7Reportlinker Adds The Future of Senior Nutrition 3A Key Ingredients Strategic Issues and Targeted Opportunities for Older Consumers 62263 8Gift Ideas for Loved Ones with Alzheimers Dementia 62258 1Gift Ideas for Loved Ones with Alzheimers Dementia 62258 2
...pital investigators have gained new insight into h...ly be reduced to a confusion of lethally malfuncti...accessorize" in order to regulate their function. ...ides warmth or an umbrella wards off rain, cells u...s (UBLs) as accessories that adapt their function ...
...08) Nanotechnology opens new worlds of possibiliti...al applications. To ensure nanotechnology is devel... Foundation (NSF) and EPA awarded $38 million to e...tions of Nanotechnology (CEINs). EPA contributed $...st award for nanotechnology research in the Agency...
...searchers have received a grant in excess of $2 mi...Medicine to determine the ideal time to fly that m...due to the rush to move them from the battlefield ... about getting these wounded soldiers to a cleaner... MD, co-principal investigator on the UC study. "O...
Other Biology News:St. Jude study gives new insights into how cells accessorize their proteins 2St. Jude study gives new insights into how cells accessorize their proteins 3Nanotechnology: A brave new world requires bold new research approaches 2US Air Force grant targets medical evacuation procedures 2US Air Force grant targets medical evacuation procedures 3US Air Force grant targets medical evacuation procedures 4
Anti-JIP 1 / 2 (SH3) Polyclonal Antibody, Unconjugated, Clone ZMD.177 from Invitrogen
Rabbit Anti-oligophrenin-1 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-Rat WAVE 1 Monoclonal Antibody, Unconjugated, Clone 1.T.4 from Abcam
Goat Anti-KV beta.1 (Q-13) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: